Masayuki Chuma

5PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)Recommender systemsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 28, 2022
Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases.

Masayuki Chuma, Hirofumi Hamano, Takashi Bando

|Apr 21, 2022
Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysis.

Masaya Kanda, Mitsuhiro Goda, Akiko Maegawa

|Mar 09, 2022
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis.

Masayuki Chuma, Aki Nakamoto, Takashi Bando

|Oct 28, 2020
Status of Institutional Review Board Meetings Conducted Through Web Conference Systems in Japanese National University Hospitals During the COVID-19 Pandemic: Questionnaire Study.

Kenta Yagi, Kazuki Maeda, Satoshi Sakaguchi

|Jul 26, 2019
Response to: Is vancomycin clearance really correlated with hemoglobin? Arguments that it's not.

Masayuki Chuma, Makoto Makishima

Pageof 1

Frequent Collaborators

1 joint publications

Kenta Yagi

1 joint publications

Kazuki Maeda

1 joint publications

Satoshi Sakaguchi

1 joint publications

Yasutaka Sato